Status:

UNKNOWN

Gene-activated Matrix for Bone Tissue Repair in Maxillofacial Surgery

Lead Sponsor:

NextGen Company Limited

Collaborating Sponsors:

Burnasyan Federal Medical Biophysical Center

Moscow State University of Medicine and Dentistry

Conditions:

Maxillofacial Bone Defects

Alveolar Bone Atrophy

Eligibility:

All Genders

18-55 years

Phase:

NA

Brief Summary

The purpose of this study is to evaluate safety and efficacy of gene-activated matrix ("Nucleostim") for regeneration of bone tissue in maxillofacial area. Patients with congenital and acquired maxill...

Detailed Description

All patients enrolled into the study will receive standard surgery procedures indicated in accordance with medical care standards for the certain disease. Maxillofacial bone defects (formed after inju...

Eligibility Criteria

Inclusion

  • obtained voluntary informed consent for participation in the clinical study;
  • congenital and acquired maxillofacial bone defects (sockets of extracted teeth, bone defects after injuries, surgeries, excision of benign neoplasms and pseudotumors, etc.) or alveolar bone atrophy.

Exclusion

  • not able or unwilling to give voluntary informed consent for the study or follow requirements of the clinical study;
  • decompensated chronic visceral diseases;
  • clinically significant laboratory abnormalities;
  • HIV, HBV and HCV antibodies in serum;
  • alcohol consumption within 4 days prior the study;
  • history of drug addiction;
  • participation in other clinical studies (or administration of study products) within 3 months prior the study;
  • conditions limiting study compliance (dementia, psycho-neurological diseases, drug addiction, alcoholism, etc.);
  • malignancies including post-surgical period with chemo- and (or) radiation therapy);
  • vascular malformations;
  • pregnancy or lactation.

Key Trial Info

Start Date :

November 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2017

Estimated Enrollment :

12 Patients enrolled

Trial Details

Trial ID

NCT02293031

Start Date

November 1 2014

End Date

December 1 2017

Last Update

March 7 2017

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Burnasyan Federal Medical Biophysical Center

Moscow, Russia

2

Moscow State University of Medicine and Dentistry

Moscow, Russia